NetworkNewsBreaks – 180 Life Sciences Corp. (NAS
Post# of 14
(Total Views: 46)
Posted On: 10/03/2024 5:03:31 PM
NetworkNewsBreaks – 180 Life Sciences Corp. (NASDAQ: ATNF) Provides Update on Strategic Corporate Initiatives
180 Life Sciences (NASDAQ: ATNF), a clinical-stage biotechnology company, has released an update on several key initiatives, including announcing the acquisition of an advanced Gaming Technology Platform, positive progress on its Legacy CBD formulation and a strengthened balance sheet. According to the update, the company is shifting its focus as it enters the global iGaming market through its acquisition of a comprehensive intellectual property package, consisting of a complete back-end technology solution for online casino operations. In addition, the company anticipates retaining its current portfolio of biotechnology intellectual property as it reports positive study results exhibiting faster absorption and improved bioavailability for its new CBD pill formulation. 180 also noted that it expects to meet NASDAQ’s continued listing requirement, which requires maintenance of stockholders’ equity of at least $2.5 million; the company is also enhancing its financial position by settling meaningful legacy liabilities at substantial discounts and resolving certain legacy litigation matters
NOTE TO INVESTORS: The latest news and updates relating to ATNF are available in the company’s newsroom at https://nnw.fm/ATNF
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer
180 Life Sciences (NASDAQ: ATNF), a clinical-stage biotechnology company, has released an update on several key initiatives, including announcing the acquisition of an advanced Gaming Technology Platform, positive progress on its Legacy CBD formulation and a strengthened balance sheet. According to the update, the company is shifting its focus as it enters the global iGaming market through its acquisition of a comprehensive intellectual property package, consisting of a complete back-end technology solution for online casino operations. In addition, the company anticipates retaining its current portfolio of biotechnology intellectual property as it reports positive study results exhibiting faster absorption and improved bioavailability for its new CBD pill formulation. 180 also noted that it expects to meet NASDAQ’s continued listing requirement, which requires maintenance of stockholders’ equity of at least $2.5 million; the company is also enhancing its financial position by settling meaningful legacy liabilities at substantial discounts and resolving certain legacy litigation matters
NOTE TO INVESTORS: The latest news and updates relating to ATNF are available in the company’s newsroom at https://nnw.fm/ATNF
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer
(0)
(0)180 Life Sciences Corp (ATNF) Stock Research Links
Scroll down for more posts ▼